Tuesday, December 6, 2022
wellness India Expo
Home Tags Biocon

Tag: Biocon

Biocon ranks No. 8 in ‘Global Top Employers’ by Science magazine

The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’

Biocon Biologics subsidiary enters Malaysia Book of Records

The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia

US FDA issues observations for Biocon Biologics sites

At the conclusion of these inspections, the agency has issued Form 483s with 11 observations each for the two sites in Bengaluru and 6 observations for the Malaysia site

CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics

The target is a subsidiary of Biocon Limited, and it offers treatment for chronic and acute diseases such as diabetes, oncology, nephrology, cancer, and autoimmune diseases

Pharma industry reiterates its commitment to US$ 130 billon by 2030

Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance

Biocon Biologics & Serum Institute Life Sciences announce strategic alliance

BBL will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets. SILS to receive ~15% stake in BBL at a post-money valuation of ~$4.9 billion......................

Syngene clocks 12% growth in FY21 revenue at Rs. 2,184 crore

Underlying revenue from operations (excluding export incentives) for the quarter grew 13% compared with the same period last year and by 12% for the full year......................

Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in...

This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil....................

Advancements in digital technology critical to advancements in clinical trials

As per experts, the digital-enabled regulatory flexibility during the pandemic that had helped bring drugs faster to market needs to continue.....................

New ‘Global Biopharma Resilience Index’ lists 5 major challenges for the...

The global index compiled by global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude has been built on the survey of 1,165 biopharma executives and healthcare policymakers across 20 countries..................